Back to Vascular Perfusion SolutionsCopy linkXLinkedInMilestoneMar 2025Q1 2025: $2.5M- IDE approval and First in HumanRVRafael VerazaMar 31, 2025IDE approval and Begin First in Human Pivotal Clinical Trial